学术论文 | 研究方向 | 招生计划
Zhong J, Guo Z, Zhao J, et al. ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy.,THORACIC CANCER,(11):2088-2095
Xue Yang , Chuan Huang , Rongrong Chen , Jun Zhao * Resolving Resistance to Osimertinib Therapy using Afatinib in a NSCLC Patient with an EGFR L718Q Mutation.,Clinical lung cancer,
Wang S, Chen H, Zhao J, et al. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.,lung cancer,135:116-122.
Yang X, Zhuo M, Zhao J, et al. Optimal first-line treatment for advanced thymic carcinoma. Thorac Cancer. 2019 Nov;10(11):2081-2087.,THORACIC CANCER,(11):2081-2087.
Zhao J, Lin G, Zhuo M, et al. Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.,lung cancer,141:114-118
Zhuo M, Guan Y, Yang X ,Zhao J *et al. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.,Clin Cancer Res,26(4):892-901
社会任职
- 北京肿瘤学会 肺癌专委会副主任委员
- 肺癌青年专家委员会 主任委员
学习、工作经历
- 2016.12.2~2020.8.12,北京大学临床肿瘤学院 胸部肿瘤内一科 主任医师 副主任
- 2011.1.1~2016.12.1,北京大学临床肿瘤学院 胸部肿瘤内一科 副主任医师 副主任
- 2005.1.5~2011.8.1,北京大学临床肿瘤学院 胸部肿瘤内一科 主治医师
- 2001.9.1~2004.9.1,北京大学临床肿瘤学院 肿瘤学 硕博连读 博士学位
- 1998.7.1~2001.9.1,北京肿瘤医院 肿瘤内科 住院医师及住院总医师